WHO director general Tedros Adhanom Ghebreyesus says this new drug—which only needs to be injected twice a year—is the next ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

A GNA feature by Laudia Sawer   Tema, July 12, GNA  -  On any ordinary morning, Maame Esi, an HIV mentor mother, stands among other mothers at the antenatal clinic ...

In the ongoing fight against HIV, scientists have taken a new step toward long-term control of the virus. Researchers have ...

Innovative, nontoxic molecules developed by a research team at the Institut national de la recherche scientifique (INRS) ...

In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a molecule within HIV itself can be manipulated and amplified to force the ...

Here’s how it works. Human immunodeficiency virus (HIV) causes a lifelong infection that, if left untreated, steadily destroys key immune cells in the body.

Chronic HIV infection is the second stage of HIV/AIDS. Learn more about what this phase is and how you can keep it from progressing to AIDS.

The "Dusseldorf patient" spoke at last week's AIDS 2024 conference in Munich. Here's what doctors did — and what they say about their ability to replicate the procedure.

A 60-year-old man in Germany has become at least the seventh person with HIV to be announced free of the virus after receiving a stem-cell transplant. But the man, who has been virus-free for ...